Sylvamo vs Scotts Miracle-Gro
Add, change or remove companies; up to four.
The short version
- Scotts Miracle-Gro is the larger business, with $3.4B of revenue in fiscal 2025 against $3.4B for Sylvamo.
- Scotts Miracle-Gro grew revenue faster (−3.9%, against −11.2%).
- Scotts Miracle-Gro kept more of each dollar of sales as operating profit (10.5% operating margin, against 7.5%).
- Scotts Miracle-Gro turned more of its sales into free cash flow (8.0% FCF margin, against 1.3%).
- Scotts Miracle-Gro earned a higher return on the capital invested in it (13.4%, against 10.9%).
- Investors pay more for each dollar of Scotts Miracle-Gro’s earnings: a P/E of 50.2x against 17.4x for Sylvamo.
| Latest fiscal year | SLVM · FY25 | SMG · FY25 |
|---|---|---|
| Size | ||
| Market cap | $1.3B | $3.5B |
| Revenue | $3.4B | $3.4B |
| Free cash flow | $44.0M | $274M |
| Net income | $132M | $145M |
| Growth | ||
| Revenue growth | −11.2% | −3.9% |
| 5-year growth | 7.0% | −3.8% |
| Share count change | −3.1% | 3.4% |
| Profitability | ||
| Gross margin | — | 30.6% |
| Operating margin | 7.5% | 10.5% |
| Net margin | 3.9% | 4.3% |
| FCF margin | 1.3% | 8.0% |
| Return on capital | 10.9% | 13.4% |
| Return on equity | 14.6% | — |
| Balance sheet | ||
| Net debt | $651M | $2.1B |
| Net debt / EBITDA | 1.5x | 4.8x |
| Dividends and buybacks | $155M | $173M |
| Valuation & quality | ||
| P/E | 17.4x | 50.2x |
| Piotroski F-score | 5 | 6 |
Revenue
FY16
SLVM —
SMG $2.5B
FY17
SLVM —
SMG $2.6B
FY18
SLVM —
SMG $2.7B
FY19
SLVM $4.0B
SMG $3.2B
FY20
SLVM $2.4B
SMG $4.1B
FY21
SLVM $2.8B
SMG $4.9B
FY22
SLVM $3.6B
SMG $3.9B
FY23
SLVM $3.7B
SMG $3.6B
FY24
SLVM $3.8B
SMG $3.6B
FY25
SLVM $3.4B
SMG $3.4B
SLVM
SMG
Operating margin
FY16
SLVM —
SMG 17.9%
FY17
SLVM —
SMG 16.4%
FY18
SLVM —
SMG 7.5%
FY19
SLVM —
SMG 13.0%
FY20
SLVM —
SMG 14.2%
FY21
SLVM —
SMG 14.7%
FY22
SLVM 15.2%
SMG −11.1%
FY23
SLVM 11.9%
SMG −4.9%
FY24
SLVM 12.0%
SMG 5.9%
FY25
SLVM 7.5%
SMG 10.5%
SLVM
SMG
Free cash flow
FY16
SLVM —
SMG $186M
FY17
SLVM —
SMG $294M
FY18
SLVM —
SMG $274M
FY19
SLVM $406M
SMG $184M
FY20
SLVM $293M
SMG $495M
FY21
SLVM $480M
SMG $165M
FY22
SLVM $289M
SMG −$243M
FY23
SLVM $294M
SMG $438M
FY24
SLVM $248M
SMG $584M
FY25
SLVM $44.0M
SMG $274M
SLVM
SMG
Return on capital
FY16
SLVM —
SMG 15.7%
FY17
SLVM —
SMG 14.1%
FY18
SLVM —
SMG 9.3%
FY19
SLVM —
SMG 13.1%
FY20
SLVM —
SMG 19.5%
FY21
SLVM 14.5%
SMG 20.8%
FY22
SLVM 29.0%
SMG −11.2%
FY23
SLVM 20.2%
SMG −5.1%
FY24
SLVM 21.9%
SMG 8.0%
FY25
SLVM 10.9%
SMG 13.4%
SLVM
SMG
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.